{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:25:55Z","timestamp":1778642755838,"version":"3.51.4"},"reference-count":82,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Omicron is an emerging SARS-CoV-2 variant, evolved from the Indian delta variant B.1.617.2, which is currently infecting worldwide. The spike glycoprotein, an important molecule in the pathogenesis and transmissions of SARS-CoV-2 variants, especially omicron B.1.1.529, shows 37 mutations distributed over the trimeric protein domains. Notably, fifteen of these mutations reside in the receptor-binding domain of the spike glycoprotein, which may alter transmissibility and infectivity. Additionally, the omicron spike evades neutralization more efficiently than the delta spike. Most of the therapeutic antibodies are ineffective against the omicron variant, and double immunization with BioNTech-Pfizer (BNT162b2) might not adequately protect against severe disease induced by omicron B.1.1.529. So far, no efficient antiviral drugs are available against omicron. The present study identified the promising inhibitors from seaweed\u2019s bioactive compounds to inhibit the omicron variant B.1.1.529. We have also compared the seaweed\u2019s compounds with the standard drugs ceftriaxone and cefuroxime, which were suggested as beneficial antiviral drugs in COVID-19 treatment. Our molecular docking analysis revealed that caffeic acid hexoside (\u22126.4 kcal\/mol; RMSD = 2.382 \u00c5) and phloretin (\u22126.3 kcal\/mol; RMSD = 0.061 \u00c5) from Sargassum wightii (S. wightii) showed the inhibitory effect against the crucial residues ASN417, SER496, TYR501, and HIS505, which are supported for the inviolable omicron and angiotensin-converting enzyme II (ACE2) receptor interaction. Cholestan-3-ol, 2-methylene-, (3beta, 5 alpha) (CMBA) (\u22126.0 kcal\/mol; RMSD = 3.074 \u00c5) from Corallina officinalis (C. officinalis) manifested the strong inhibitory effect against the omicron RBD mutated residues LEU452 and ALA484, was magnificently observed as the essential residues in Indian delta variant B.1.617.2 previously. The standard drugs (ceftriaxone and cefuroxime) showed no or less inhibitory effect against RBD of omicron B.1.1.529. The present study also emphasized the pharmacological properties of the considered chemical compounds. The results could be used to develop potent seaweed-based antiviral drugs and\/or dietary supplements to treat omicron B.1.1529-infected patients.<\/jats:p>","DOI":"10.3390\/md20020148","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:25:45Z","timestamp":1645129545000},"page":"148","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3235-5837","authenticated-orcid":false,"given":"Muruganantham","family":"Bharathi","sequence":"first","affiliation":[{"name":"Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5499-8350","authenticated-orcid":false,"given":"Bhagavathi Sundaram","family":"Sivamaruthi","sequence":"additional","affiliation":[{"name":"Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-0947","authenticated-orcid":false,"given":"Periyanaina","family":"Kesika","sequence":"additional","affiliation":[{"name":"Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subramanian","family":"Thangaleela","sequence":"additional","affiliation":[{"name":"Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-2419","authenticated-orcid":false,"given":"Chaiyavat","family":"Chaiyasut","sequence":"additional","affiliation":[{"name":"Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"ref_1","unstructured":"(2022, January 19). World Health Organization. Available online: https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern 2021."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijid.2021.12.357","article-title":"Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in Tshwane, South Africa","volume":"116","author":"Abdullah","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID\u2019s role in pandemic response","volume":"3","author":"Khare","year":"2021","journal-title":"China CDC Wkly"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/d41586-021-03608-x","article-title":"Omicron-variant border bans ignore the evidence, say scientists","volume":"7888","author":"Mallapaty","year":"2021","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mannar, D., Saville, J.W., Zhu, X., Srivastava, S.S., Berezuk, A.M., Tuttle, K.S., Marquez, A.C., Sekirov, I., and Subramaniam, S. (2022). SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science, eabn7760.","DOI":"10.1101\/2021.12.19.473380"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Alenquer, M., Ferreira, F., Lousa, D., Val\u00e9rio, M., MedinaLopes, M., Bergman, M.-L., Goncalves, J., Demengeot, J., Leite, R.B., and Lilue, J. (2021). Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009772"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41564-021-00974-0","article-title":"Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern","volume":"6","author":"Dupont","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"105226","DOI":"10.1016\/j.compbiomed.2022.105226","article-title":"SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody","volume":"142","author":"Omotuyi","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102242","DOI":"10.1016\/j.tmaid.2021.102242","article-title":"Omicron N501Y mutation among SARS-CoV-2 lineages: In silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine","volume":"45","author":"Kazybay","year":"2021","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ramesh, S., Govindarajulu, M., Parise, R.S., Neel, L., Shankar, T., Patel, S., Lowery, P., Smith, F., Dhanasekaran, M., and Moore, T. (2021). Emerging SARS-CoV-2 variants: A review of its mutations, its implications and vaccine efficacy. Vaccines, 9.","DOI":"10.3390\/vaccines9101195"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s42003-021-02728-4","article-title":"Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization","volume":"4","author":"Zhang","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1126\/science.abe9728","article-title":"Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","volume":"371","author":"Buss","year":"2021","journal-title":"Science"},{"key":"ref_13","first-page":"100998","article-title":"Omicron SARS-CoV-2 variant: What we know and what we don\u2019t","volume":"41","author":"Visseaux","year":"2021","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mco2.110","article-title":"SARS-CoV-2 Omicron variant: Characteristics and prevention","volume":"2","author":"He","year":"2021","journal-title":"MedComm"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102234","DOI":"10.1016\/j.tmaid.2021.102234","article-title":"Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts\u2014What is known so far?","volume":"45","author":"Poudel","year":"2021","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_16","unstructured":"Aleem, A., Samad, A.A.B., and Slenker, A.K. (2021). Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19), StatPearls Publishing."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/acs.jcim.1c01451","article-title":"Omicron variant (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance","volume":"62","author":"Chen","year":"2022","journal-title":"J. Chem. Inf. Model"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111330","DOI":"10.1016\/j.biopha.2021.111330","article-title":"Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines","volume":"137","author":"Awadasseid","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/22221751.2021.2023330","article-title":"Omicron: A drug developer\u2019s perspective","volume":"11","author":"Fang","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s10811-014-0304-8","article-title":"Seaweeds: An opportunity for wealth and sustainable livelihood for coastal communities","volume":"26","author":"Rebours","year":"2014","journal-title":"J. Appl. Phycol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"150445","DOI":"10.1016\/j.scitotenv.2021.150445","article-title":"Influence of seawater acidification on biochemical composition and oxidative status of green algae Ulva Compressa","volume":"806","author":"Vinuganesh","year":"2022","journal-title":"Sci. Total. Environ."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/nure.12091","article-title":"Seaweed and human health","volume":"72","author":"Brown","year":"2014","journal-title":"Nutr. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10811-016-0974-5","article-title":"Algae as nutritional and functional food sources: Revisiting our understanding","volume":"29","author":"Wells","year":"2017","journal-title":"J. Appl. Phycol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pe\u00f1alver, R., Lorenzo, J.M., Ros, G., Amarowicz, R., Pateiro, M., and Nieto, G. (2020). Seaweeds as a functional ingredient for a healthy diet. Mar. Drugs, 18.","DOI":"10.3390\/md18060301"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chen, K.K., Minakuchi, M., Wuputra, K., Ku, C.C., Pan, J.B., Kuo, K.K., Lin, Y.C., Saito, S., Lin, C.S., and Yokoyama, K.K. (2020). Redox control in the pathophysiology of influenza virus infection. BMC Microbiol., 20.","DOI":"10.1186\/s12866-020-01890-9"},{"key":"ref_26","first-page":"1543","article-title":"COVID-19 and oxidative stress","volume":"85","author":"Chernyak","year":"2020","journal-title":"Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ijbiomac.2011.08.026","article-title":"In vitro antioxidant activities of sulfated polysaccharide fractions extracted from Corallina officinalis","volume":"49","author":"Yang","year":"2011","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ismail, M.M., Alotaibi, B.S., and El-Sheekh, M.M. (2020). Therapeutic uses of red macroalgae. Molecules, 25.","DOI":"10.3390\/molecules25194411"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yap, W.F., Tay, V., Tan, S.H., Yow, Y.Y., and Chew, J. (2019). Decoding antioxidant and antibacterial potentials of Malaysian green seaweeds: Caulerpa racemosa and Caulerpa Lentillifera. Antibiotics, 8.","DOI":"10.3390\/antibiotics8030152"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pangestuti, R., Haq, M., Rahmadi, P., and Chun, B.S. (2021). Nutritional value and biofunctionalities of two edible green seaweeds (Ulva lactuca and Caulerpa racemosa) from Indonesia by subcritical water hydrolysis. Mar. Drugs, 19.","DOI":"10.3390\/md19100578"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/14737159.2021.1941880","article-title":"Blood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality","volume":"21","author":"Lorente","year":"2021","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Monla, A.R., Dassouki, Z., Kouzayha, A., Salma, Y., Gali-Muhtasib, H., and Mawlawi, H. (2020). The cytotoxic and apoptotic effects of the brown algae Colpomenia sinuosa are mediated by the generation of reactive oxygen species. Molecules, 25.","DOI":"10.3390\/molecules25081993"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rosemary, T., Arulkumar, A., Paramasivam, S., Mondragon-Portocarrero, A., and Miranda, J.M. (2019). Biochemical, micronutrient and physicochemical properties of the dried red seaweeds Gracilaria edulis and Gracilaria Corticata. Molecules, 24.","DOI":"10.3390\/molecules24122225"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"653562","DOI":"10.3389\/fmicb.2021.653562","article-title":"Metabolite profiling of malaysian Gracilaria edulis reveals eplerenone as novel antibacterial compound for drug repurposing against MDR bacteria","volume":"12","author":"Asghar","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/md15010019","article-title":"New enzyme-inhibitory triterpenoid from marine macro brown alga Padina boergesenii allender & kraft","volume":"15","author":"Ali","year":"2017","journal-title":"Mar. Drugs"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40071-018-0193-6","article-title":"Effect of dietary Sargassum wightii and its fucoidan-rich extract on growth, immunity, disease resistance and antimicrobial peptide gene expression in Labeo rohita","volume":"10","author":"Gora","year":"2018","journal-title":"Int. Aquat. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1007\/s13197-019-03943-y","article-title":"Effect of indian brown seaweed Sargassum wightii as a functional ingredient on the phytochemical content and antioxidant activity of coffee beverage","volume":"56","author":"Kumar","year":"2019","journal-title":"J. Food Sci. Technol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 1.2.0: New docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-010-9395-8","article-title":"Computer-aided drug design platform using PyMOL","volume":"25","author":"Lill","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_42","unstructured":"Grob, S. (2022, January 15). Slovakia. Molinspiration Cheminformatics Free Web Services. Available online: https:\/\/www.molinspiration.com."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: A webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","article-title":"Protein Data Bank (PDB): The single global macromolecular structure archive","volume":"1607","author":"Burley","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: New data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_47","first-page":"33","article-title":"Open Babel: An open chemical toolbox","volume":"73","author":"Banck","year":"2011","journal-title":"J. Cheminform."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"197989","DOI":"10.1016\/j.virusres.2020.197989","article-title":"Natural product-derived phytochemicals as potential agents against coronaviruses: A review","volume":"284","author":"Mani","year":"2020","journal-title":"Virus Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"599079","DOI":"10.3389\/fmolb.2020.599079","article-title":"In silico screening of natural compounds as potential inhibitors of SARS-CoV-2 main protease and spike RBD: Targets for COVID-19","volume":"7","author":"Teli","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Bharathi, M., Sivamaruthi, B.S., Kesika, P., Thangaleela, S., and Chaiyasut, C. (2022). In silico screening of potential phytocompounds from several herbs against sars-cov-2 indian delta variant b.1.617.2 to inhibit the spike glycoprotein trimer. Appl. Sci., 12.","DOI":"10.3390\/app12020665"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.dsx.2020.04.015","article-title":"Enhancing immunity in viral infections, with special emphasis on COVID-19: A review","volume":"14","author":"Jayawardena","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Leandro, A., Pacheco, D., Cotas, J., Marques, J.C., Pereira, L., and Gon\u00e7alves, A.M.M. (2020). Seaweed\u2019s bioactive candidate compounds to food industry and global food security. Life, 10.","DOI":"10.3390\/life10080140"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s43450-021-00179-w","article-title":"The role of micronutrients to support immunity for covid-19 prevention","volume":"31","author":"Ahmed","year":"2021","journal-title":"Rev. Bras. Farmacogn."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/nutrit\/nuaa126","article-title":"Potential benefits of dietary seaweeds as protection against COVID-19","volume":"79","author":"Tamama","year":"2021","journal-title":"Nutr. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/v13091817","article-title":"Potential antiviral properties of industrially important marine algal polysaccharides and their significance in fighting a future viral pandemic","volume":"13","author":"Bai","year":"2021","journal-title":"Viruses"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMc2119270","article-title":"Effectiveness of BNT162b2 vaccine against omicron variant in South Africa","volume":"386","author":"Collie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Peiris, M., Cheng, S., Mok, C.K.P., Leung, Y., Ng, S., Chan, K., Ko, F., Yiu, K., Lam, B., and Lau, E. (2022). Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines. Res. Sq., rs.3.rs-1207071. Preprint.","DOI":"10.21203\/rs.3.rs-1207071\/v1"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1080\/07391102.2020.1777904","article-title":"Repurposing cefuroxime for treatment of COVID-19: A scoping review of in silico studies","volume":"39","author":"Durojaiye","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s41182-021-00344-w","article-title":"The use of antibiotics in COVID-19 management: A rapid review of national treatment guidelines in 10 African countries","volume":"49","author":"Adebisi","year":"2021","journal-title":"Trop. Med. Health."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3855\/jidc.14404","article-title":"Use of antibiotics in COVID-19 ICU patients","volume":"15","author":"Mustafa","year":"2021","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"570919","DOI":"10.3389\/fimmu.2020.570919","article-title":"Perspective: The potential effects of naringenin in COVID-19","volume":"11","author":"Alberca","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42269-020-00479-6","article-title":"Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: An in silico molecular modeling approach in battling the COVID-19 outbreak","volume":"45","author":"Shawan","year":"2021","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Wu, L., Zhou, L., Mo, M., Liu, T., Wu, C., Gong, C., Lu, K., Gong, L., Zhu, W., and Xu, Z. (2021). The effect of the multiple mutations in Omicron RBD on its binding to human ACE2 receptor and immune evasion: An investigation of molecular dynamics simulations. ChemRxiv. Camb. Camb. Open Engag., Preprint.","DOI":"10.26434\/chemrxiv-2021-n23f5"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"735768","DOI":"10.3389\/fchem.2021.735768","article-title":"Characterization of phytochemicals in Ulva intestinalis L. and their action against SARS-CoV-2 spike glycoprotein receptor-binding domain","volume":"27","author":"Kulkarni","year":"2021","journal-title":"Front. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"153310","DOI":"10.1016\/j.phymed.2020.153310","article-title":"Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19","volume":"85","author":"Adem","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3892\/ijmm.2014.1859","article-title":"Inhibition by caffeic acid of the influenza A virus multiplication in vitro","volume":"34","author":"Utsunomiya","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jiac.2018.03.005","article-title":"Caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitro","volume":"24","author":"Ogawa","year":"2018","journal-title":"J. Infect. Chemother. Off. J. Jpn. Soc. Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.antiviral.2018.10.021","article-title":"Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses","volume":"160","author":"Langland","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2050312121991246","DOI":"10.1177\/2050312121991246","article-title":"Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria","volume":"9","author":"Muhammad","year":"2021","journal-title":"SAGE Open Med."},{"key":"ref_71","first-page":"287","article-title":"First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid","volume":"54","author":"Ighodaro","year":"2018","journal-title":"Alex. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Beltr\u00e1n-Garc\u00eda, J., Osca-Verdegal, R., Pallard\u00f3, F.V., Ferreres, J., Rodr\u00edguez, M., Mulet, S., Sanchis-Gomar, F., Carbonell, N., and Garc\u00eda-Gim\u00e9nez, J.L. (2020). Oxidative stress and inflammation in COVID-19-associated sepsis: The potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants, 9.","DOI":"10.3390\/antiox9100936"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11101-017-9500-x","article-title":"Health effects of phloretin: From chemistry to medicine","volume":"16","author":"Sureda","year":"2017","journal-title":"Phytochem. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Fadaka, A.O., Sibuyi, N.R.S., Martin, D.R., Klein, A., Madiehe, A., and Meyer, M. (2021). Development of effective therapeutic molecule from natural sources against coronavirus protease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179431"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/C8MD00472B","article-title":"ADMET-score\u2014A comprehensive scoring function for evaluation of chemical drug-likeness","volume":"10","author":"Guan","year":"2018","journal-title":"Medchemcomm"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Benkerroum, N. (2020). Chronic and acute toxicities of aflatoxins: Mechanisms of action. Int. J. Environ. Res. Public Health., 17.","DOI":"10.3390\/ijerph17020423"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.apsb.2019.05.004","article-title":"Structural simplification: An efficient strategy in lead optimization","volume":"9","author":"Wang","year":"2019","journal-title":"Acta. Pharm. Sin. B."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"409","DOI":"10.6026\/97320630003409","article-title":"Role of large hydrophobic residues in proteins","volume":"3","author":"Jayaraj","year":"2009","journal-title":"Bioinformation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e1007318","DOI":"10.1371\/journal.pcbi.1007318","article-title":"A lipophilicity-based energy function for membrane-protein modelling and design","volume":"15","author":"Weinstein","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"ref_81","first-page":"971258","article-title":"Prediction and analysis of surface hydrophobic residues in tertiary structure of proteins","volume":"2014","author":"Gowder","year":"2014","journal-title":"Sci. World J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","article-title":"BDDCS, the Rule of 5 and drugability","volume":"101","author":"Benet","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/20\/2\/148\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:21:53Z","timestamp":1760134913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/20\/2\/148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":82,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["md20020148"],"URL":"https:\/\/doi.org\/10.3390\/md20020148","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}